Skip to main content
Sign inSign up

AAPP Society

Logo
AboutIssues

AAPP Society

About This Journal

The Mental Health Clinician (MHC) is a peer-reviewed, bimonthly, clinical practice journal indexed in PubMed and PubMed Central (PMC). The MHC delves into new topics with each issue to provide psychiatric and neurologic pharmacists’... Read More

Submit an Article

A retrospective review of intramuscular olanzapine and parenteral benzodiazepine coadministration in the emergency department

Jessica LaubPharmD, BCEMP,
Cierra N. TreuPharmD, BCCCP,
Kei TakamuraPharmD, BCPS, BCPP, and
Christopher MendozaMD, FACEP

Evaluation of a student pharmacist–led depression screening program in a community pharmacy

Shannon HabbaBS,
Kyle BurghardtPharmD, and
Brittany StewartRD, PharmD

High frequency of clozapine-associated myocarditis and troponin elevation: Need for slower titration prospective studies

Yuki KikuchiMD,
Bunichiro OnoderaMD,
Hiroshi KomatsuMD, PhD, and
Hiroaki TomitaMD, PhD

Features & Information

Psychiatric Pharmacists Image

 

With $238 billion being spent on mental health each year and the growing shortage of psychiatrists, clinical pharmacists will continue to play an essential role on mental health teams. Discover the benefits of having a psychiatric pharmacist as part of the team in collaboration with the health care team, patients and caregivers by downloading these informative resources.

mhc-psychotropic-image

 

AAPP’s psychotropic LAI training programs are designed to expand patient access to these medications by reducing barriers and increasing pharmacist comfort with administration services. A multitude of helpful resources are available to equip pharmacists with the tools necessary to lead, innovate, and advance LAI patient care and clinic management.

Career Feature Image

 

The demand for psychiatric services to treat psychiatric and neurological disorders has dramatically increased. Psychiatric pharmacists can help meet this demand by working with a physician as part of a collaborative team to improve medication-related outcomes for patients with psychiatric or neurological disorders.

AboutIssuesAdvertisingPermissions

MHC logoAAAP Society Logo

eISSN: 2168-9709

Powered by PubFactory